A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson &amp; Johnson)

Maxime Castan; Maxime Castan; Marlène Damin-Pernik; Marlène Damin-Pernik; Guillaume Thiéry; Guillaume Thiéry; Dominique Page; Dominique Page; David M. Smadja; David M. Smadja; Laurent Bertoletti; Laurent Bertoletti

doi:10.1016/j.therap.2022.01.014

Back

A case report of vaccine-induced immune thrombocytopenia and thrombosis syndrome after Ad26.COV2.S vaccine (Janssen/Johnson & Johnson)

Letter 2022 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination

Jimin Hwang, Young Joo Han, Dong Keon Yon, Seung Won Lee, Beom Kyung Kim, Se Bee Lee, Min Ho Lee, Seung Hyun Park, Ai Koyanagi, Louis Jacob, Kalthoum Tizaoui, Seung Up Kim, Jae Il Shin, Lee Smith

Article2022

Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis

Ah Young Kim, Wongi Woo, Dong Keon Yon, Seung Won Lee, Jae Won Yang, Ji Hong Kim, Seoyeon Park, Ai Koyanagi, Min Seo Kim, Sungsoo Lee, Jae Il Shin, Lee Smith

Article2021

Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines

Jimin Hwang, Se Bee Lee, Seung Won Lee, Min Ho Lee, Ai Koyanagi, Louis Jacob, Kalthoum Tizaoui, Dong Keon Yon, Jae Il Shin, Lee Smith

Article2023

SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia: A comprehensive review, release 1 (epidemiologic perspective)

Kalthoum Tizaoui, Inès Zidi, Masoud Rahmati, Ai Koyanagi, Andreas Kronbichler, Michael Eisenhut, Jae Il Shin, Lee Smith